Advertisement

Clinical Manifestations

  • LI Hongjun
  • LI Ning
Chapter
  • 865 Downloads

Abstract

The incubation period after infection of Influenza A(H1N1) is usually 1–7 days, being longer than common influenza and bird flu.

Keywords

Acute Respiratory Distress Syndrome Severe Acute Respiratory Syndrome Sore Throat Severe Pneumonia Bacterial Pneumonia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

5.1 Clinical Manifestations

5.1.1 Incubation Period

The incubation period after infection of Influenza A (H1N1) is usually 1–7 days, being longer than common influenza and bird flu.

5.1.2 Clinical Characteristics

After the infection of Influenza A (H1N1) virus, the clinical symptoms range from no fever and mild symptoms of upper respiratory infection to severe or fatal pneumonia. Most patients suffering from Influenza A (H1N1) have typical flu-like symptoms, being capable of spontaneous recovery. The most common symptoms include coughing, fever, sore throat, headache and upset. Some out-patients may not be found feverish, and about 38 % American out-patients have gastrointestinal symptoms, including nausea, vomiting and/or diarrhea.

About 2–5 % definitely diagnosed patients in the US and Canada and 6 % in Mexico were hospitalized for treatment. Among Mexican patients with acute respiratory infections, 13 % were tested positive for Influenza A (H1N1) virus and 20 % were diagnosed as having seasonal influenza. In the patients diagnosed as having Influenza A (H1N1) in Mexico, 10 % were hospitalized and 1/3 hospitalized patients received mechanical ventilation.

Almost half of the hospitalized patients in the US and 46 % Mexican death cases were found underlying conditions including pregnancy, asthma, other pulmonary diseases, diabetes, obesity, autoimmune diseases treated with immunosuppressive therapy, neurological diseases and cardiovascular diseases. Among 30 hospitalized patients in California of the US, 64 % had background diseases.

Among 45 death cases in Mexico, 54 % were healthy, mostly aged 20–59 years [1, 2]. Adults had a higher mortality rate than children and teenagers. Death usually occurred due to the rapid development of respiratory conditions. In Mexico, the period from the onset of disease to hospitalization was averagely 6 days (ranging from 1 to 20 days), but a mean of 4 days in the US. The clinical manifestations of the death cases were fever, tachypnea, myalgia, tachycardia, low oxygen saturation and occasional hypotension and cyanosis. The severe cases had cardiac arrest in a short period after hospitalization.

In Mexico, chest X-ray of patients with severe pneumonia demonstrated multifocal infiltration. The condition might rapidly develop into acute respiratory distress syndrome (ARDS), renal or multiple-organ failure [3, 4, 5, 6]. The median period from the onset of the disease to death was about 10 days, ranging from 2 to 23 days. Among the hospitalized patients in California, 60 % (15/25) were radiologically diagnosed as having pneumonia.

The hospitalized patients had both increase and decrease of white cell counts. In Mexico, many hospitalized patients were found to have decreased lymph cells, increased transaminase and lactate dehydrogenase levels. Some were found to have very high level of creatinine. Half of the hospitalized patients had renal dysfunction of different severity, which might be secondary to rhabdomyolysis and myoglobinuria.

5.1.3 Clinical Symptoms

The early symptoms of Influenza A (H1N1) are similar to common human influenza, including fever, cough, sore throat, somatic pain, headache, chills, and fatigue. Some patients may have diarrhea/vomiting, muscle pain/fatigue and redness of eyes.

The symptoms may deteriorate rapidly, being sudden and severe. The severe symptoms include sudden high fever over 39 °C, even with secondary complications of severe pneumonia, ARDS, pneumorrhagia, pleural effusion, pancytopenia, renal failure, sepsis, shock and Reye syndrome, respiratory failure and multiple organs failure to cause death. The patients’ background diseases may deteriorate [7, 8, 9, 10, 11].

5.1.4 Clinical Signs

The abnormal signs of lungs are not obvious. Some patients may be found moist rale or pulmonary parenchymal changes.

The fatal clinical signs include difficulty breathing, ARDS and multiple organs failure.

5.1.5 Clinical Course

For most patients with Influenza A (H1N1), recovery usually can be achieved within a week after positive treatment by clinical physicians. And for some patients, the clinical course may be longer.

Clinical data indicated that the mortality rate of patients with Influenza A (H1N1) is about 6 % and the cause of death is commonly severe secondary complications. The period from the onset of symptoms to death is averagely 9 days, but the mortality rate is lower than those of bird flu and severe acute respiratory syndrome (SARS).

5.2 Clinical Complications

The serious illness or death of the patients is primarily due to complications. These complications include primary viral pneumonia and secondary bacterial pneumonia (especially group A streptococcal pneumonia and staphylococcus aureus pneumonia).

References

  1. 1.
    Bin C, Xingwang L, Yu M, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009;361:2507–17.CrossRefGoogle Scholar
  2. 2.
    Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605–15.CrossRefGoogle Scholar
  3. 3.
    Hongjun L, Ning L, Ronghua J, et al. A-H1N1 pneumonia: a case report. Chin J Radiol. 2009;43:1337–8.Google Scholar
  4. 4.
    Hongjun L, Jingliang C, Ning L, et al. Critical influenza (H1N1) pneumonia: imaging manifestations and histopathological findings. Chin Med J (Engl). 2012;125:2109–14.Google Scholar
  5. 5.
    Ying Y, Xiaofeng T, Yuxin S, et al. Initial HRCT findings of novel influenza A (H1N1) infection. Influenza Other Respi Viruses. 2012;6:e114–19.CrossRefGoogle Scholar
  6. 6.
    Feng C, Dawei Z, Hongjun L, et al. Imaging findings of severe and critical severe pulmonary infections with A H1N1 influenza. Chin J Radiol. 2010;44:123–6.Google Scholar
  7. 7.
    Peiris JS, Poon LL, Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol. 2009;45:169–73.PubMedCrossRefGoogle Scholar
  8. 8.
    Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374:451–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med. 2009;361:1935–44.PubMedCrossRefGoogle Scholar
  10. 10.
    Bin C, Xingwang L, Yuelong S, et al. Clinical and epidemiologic characteristics of 3 early cases of influenza A pandemic (H1N1) virus 2009 infection, People’s Republic of China, 2009. Emerg Infect Dis. 2009;15:1418–22.PubMedCrossRefGoogle Scholar
  11. 11.
    Lu B, Li G, Bin C, et al. Clinical features of pneumonia caused by 2009 influenza A(H1N1) virus in Beijing, China. Chest. 2011;139:1156–64.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., Dordrecht and Tsinghua University Press 2013

Authors and Affiliations

  • LI Hongjun
    • 1
  • LI Ning
    • 2
  1. 1.Radiology DepartmentCapital Medical University Beijing You’an HospitalBeijingChina, People’s Republic
  2. 2.Capital Medical University Beijing You’an HospitalBeijingChina, People’s Republic

Personalised recommendations